Tag: immunotherapy

Podcast: Developing Novel viral Immunotherapies to Improve Cancer Outcomes

Join us in this eye-opening YouTube video as we introduce Dr. Paul Peter Tak, a trailblazer in the field of biotechnology and the President, Chief Executive Officer, and a Board member of Candel Therapeutics. Dive into the world of ground-breaking viral immunotherapies designed to induce immunogenic cell death within cancer cells right at the injection site. Dr. Tak leads the charge in developing and commercializing these novel therapies, emphasizing the unmasking of tumour neo-antigens within an activated microenvironment. Discover how this strategic approach aims to trigger a systemic, enduring immune response against tumours, with the potential to revolutionize outcomes across a spectrum of indications. Don’t miss out on this exclusive insight into the future of cancer treatment and the game-changing work at Candel Therapeutics. Subscribe now and stay at the forefront of cutting-edge medical advancements!

A message to the Candel Therapeutics team and stakeholders

Watch this short video featuring Dr. Paul-Peter Tak, as he expresses heartfelt gratitude to the dedicated team at Candel Therapeutics. In this video, Dr. Tak extends his appreciation to the invaluable contributions of the staff, patients, collaborators, and investors who have been instrumental in the groundbreaking work conducted at Candel. Gain a deeper understanding of why Candel Therapeutics’ mission is so crucial in the realm of cancer treatment. Dr. Tak sheds light on the importance of their work, emphasizing the significance of oncolytic viral immunotherapies in inducing immunogenic cell death, creating a pro-inflammatory microenvironment, and fostering a systemic immune response against cancer cells.

Paul Peter Tak

© Paul Peter Tak.
All rights reserved.